rev1 engineering and filmecc- medical device design and manufacturing logo

Rev.1 Engineering Presents at LSI 2024

Table of Contents
Upcoming Events
Michael Groosman presents Rev.1 Engineering at LSI ’24.


We are an engineering contract development company. We’re based in Temecula and Murrieta, right in between Irvine and San Diego. The company got founded back in 2008 by two former Guidant engineers, but we’ve grown since to about 50 people, 35 engineers and technicians where we developed over 150 devices for more than 80 clients, both domestic and international. We got acquired back in 2021 by Asahi Intecc.

Since then, we have added our ISO 13485 certificate and we have added strategic manufacturing to our development capabilities. So, we are a part of Asahi Intecc. We are very independent in how we operate so we can choose who we want to work with in whatever field. But because we are a group company, we have the possibility to source components from them for very good rates and expedited lead times.

And if the opportunity is there, we can also scale to their large-scale manufacturing sites in Southeast Asia. Core business is custom device development and early manufacturing. We have worked on several occasions with startup innovators, where we act as their entire development team and take them from back of the napkin sketch all the way to a transfer to manufacturing and commercialization.

We also work on our cards. If you just need a temporary extension of your core team and ready to do product development, just the DFM activities or V, this is something that we can do and then go separate ways again, tend to create a lot of IP during these phases. We don’t own any of our own of this IP.

We always assign it to our clients. We have experience in a lot of fields and we’re very agnostic to what type of work we take on. But I would say that about 50% to 60% of what we have done is either minimally invasive instruments or catheter-based devices for both mechanical delivery and energy delivery. But we also have experience in drug device combinations to wearables, to capital equipment as well.

We like to work in all these different fields because it gives us a lot of opportunity to cross-pollinate, which makes us work especially well with first-of-kind type of device innovators, because we can source from these types of different experiences. We have a lot of capabilities. We have our own machine shop, but we can also source from Asahi Inntec to facilitate rapid prototyping and importantly, we have a strategic manufacturing site locally in Murietta, in California.

We wanted to start this strategic manufacturing side because we noticed working with our startup innovators how difficult it can sometimes be to get a contract manufacturer, especially at an early stage. So typical contract manufacturers, ones who have high volumes, long runs, predictable demands, which is something that a startup usually cannot offer at an early stage. We want to be that manufacturing sites where you can do variable volumes, short runs, and we evolve with your demands just to make sure that you have the products available.

Did your V&V and your clinical trials get the data and then get next to that next funding round? At end of my presentation, I’ll be around here. Feel free to reach out to me through the app or just come over to Temecula. We’d be happy to have you over. Thank you very much.